Homeopathy for Acute Viral Infections: A Bayesian Repertory for Reliable Use of Common Symptoms

Abstract

A recent worldwide COVID-19 case collection assessed the prevalence and likelihood ratio (LR) of symptoms, resulting in a bayesian repertory and repertorization app. This approach resulted in a clear and reliable differentiation between selected medicines, with common symptoms, combined or separately. The assessed COVID-19 symptoms are mostly common symptoms and occur in several other acute viral infections. Common symptoms are symptoms, throughout the body, common to most viral infectious disease, for example, fever, headache, weakness, etc. Use of this repertory and app is likely to improve the effectiveness of homeopathy in these infections due to the hierarchical approach built within the app to categorize the unique combination of common symptoms specific to each case. The use of the online app is free of charge. This offers an opportunity to experience the usefulness of common symptoms with the bayesian approach in case evaluation. This repertory could be a showcase of homeopathic treatment based on systematic and reproducible data collection. We invite practitioners to test the app in daily practice while treating acute viral infections and give feedback via the new button at the last screen of the app.

Keywords

homeopathy - acute viral infections - Bayes' theorem - common symptoms - repertory

Publikationsverlauf

Artikel online veröffentlicht:
10. Januar 2024

• References

• 1 Wang D, Hu B, Hu C. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323 (11) 1061-1069
• 2 To KLA, Fok YYY. Homeopathic clinical features of 18 patients in COVID-19 outbreaks in Hong Kong. Homeopathy 2020; 109 (03) 146-162
• 3 Masiello DJ. The COVID-19 pandemic: a view from New York City. Homeopathy 2020; 109 (03) 163-166
• 4 Rossi EG. The experience of an Italian public homeopathy clinic during the COVID-19 epidemic, March-May 2020. Homeopathy 2020; 109 (03) 167-168
• 5 Waisse S, Oberbaum M, Frass M. The hydra-headed coronaviruses: implications of COVID-19 for homeopathy. Homeopathy 2020; 109 (03) 169-175
• 6 Daruiche PSJ, Canoas WS, GoncalvesFigueira KA, Peres GB. Homeopathy for COVID-19 prevention: report of an intervention at a Brazilian service sector company. Homeopathy 2021; 110: 1-9
• 7 Clapers ML, Velat M, Clapers JM, Vidal-Jové J, Mora J. Analysis of homeopathic Genus epidemicus for COVID-19 Patients in Spain. Homeopathy 2021; 110 (04) 236-243
• 8 de La Luz Escalante HM, Hasa N, Delgado AG, Soto SG, Vivas J. A group of homoeopathic medicines for COVID-19: a systematic review of clinical features. Indian J Res Homoeopathy 2021; 15: 123-136
• 9 Jethani B, Gupta M, Wadhwani P. et al. Clinical characteristics and remedy profiles of patients with COVID-19: a retrospective cohort study. Homeopathy 2021; 110 (02) 86-93
• 10 Stolper CF, Rutten ALB, Lugten RFG, Barthels RJ. Improving homeopathic prescribing by applying epidemiological techniques: the role of likelihood ratio. Homeopathy 2002; 91 (04) 230-238
• 11 Manchanda RK, Miglani A, Chakraborty M. et al. Impact of bias in data collection of COVID-19 cases. Homeopathy 2022; 111 (01) 57-65
• 12 Rutten L, Smedley T, Ives G. et al. Data collection during the COVID-19 pandemic: learning from experience, resulting in a bayesian repertory. Homeopathy 2021; 110 (02) 94-101
• 13 Miglani A, Manchanda RK, Kalsi A. et al. Test of a homeopathic algorithm for COVID-19: the importance of a broad perspective. Homeopathy 2023; 112 (01) 22-29
• 14 Vaishampayan S, Mutreja K, Lambe S, Shah J, Shaikh G. Mercurius solubilis as Genus epidemicus for the COVID-19 pandemic. Homeopathy 2020; 109 (04) 271-272
• 15 Miglani A, Rutten L, Manchanda RK. Generalisability of prognostic factor research: further analysis of data from the IIPCOS2 study. Homeopathy 2017; 106 (03) 155-159